帕博利珠单抗治疗后蕈样肉芽肿从斑块期迅速进展至肿瘤期。 - Suppr

Suppr

超能文献

Abrupt progression from patch- to tumor-stage mycosis fungoides following pembrolizumab treatment.

作者信息

Kim Gyeong Hoon, Jung Joon Min, Lee Woo Jin, Won Chong Hyun, Chang Sung Eun, Lee Mi Woo

机构信息

Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

出版信息

JAAD Case Rep. 2024 May 6;49:129-131. doi: 10.1016/j.jdcr.2024.03.028. eCollection 2024 Jul.

DOI:10.1016/j.jdcr.2024.03.028

PMID:39040160

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11261752/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b081/11261752/40c32ecff1a7/gr1.jpg

相似文献

Abrupt progression from patch- to tumor-stage mycosis fungoides following pembrolizumab treatment.帕博利珠单抗治疗后蕈样肉芽肿从斑块期迅速进展至肿瘤期。

JAAD Case Rep. 2024 May 6;49:129-131. doi: 10.1016/j.jdcr.2024.03.028. eCollection 2024 Jul.

Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 study.局部注射 TTI-621，一种新型针对固有免疫检查点 CD47 的生物制剂，用于治疗复发或难治性蕈样真菌病或塞扎里综合征患者：一项多中心、1 期研究。

Lancet Haematol. 2021 Nov;8(11):e808-e817. doi: 10.1016/S2352-3026(21)00271-4. Epub 2021 Oct 7.

Clinical Response in Heavily Pretreated Mycosis Fungoides with Pembrolizumab: A Case Report.帕博利珠单抗治疗广泛预处理蕈样肉芽肿的临床反应：一例报告。

Acta Haematol. 2022;145(2):207-209. doi: 10.1159/000518815. Epub 2021 Oct 13.

Pembrolizumab and palliative radiotherapy in 2 cases of refractory mycosis fungoides.帕博利珠单抗与姑息性放疗治疗2例难治性蕈样肉芽肿

JAAD Case Rep. 2020 Nov 6;7:87-90. doi: 10.1016/j.jdcr.2020.10.025. eCollection 2021 Jan.

Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides.泛发性斑片和/或斑块（T2）蕈样肉芽肿患者的临床特征和长期预后

Arch Dermatol. 1999 Jan;135(1):26-32. doi: 10.1001/archderm.135.1.26.

Expression of immune checkpoint molecules programmed death protein 1, programmed death-ligand 1 and inducible T-cell co-stimulator in mycosis fungoides and Sézary syndrome: association with disease stage and clinical outcome.蕈样肉芽肿和塞扎里综合征中免疫检查点分子程序性死亡蛋白 1、程序性死亡配体 1 和诱导型 T 细胞共刺激分子的表达：与疾病阶段和临床结局的关联。

Br J Dermatol. 2022 Aug;187(2):234-243. doi: 10.1111/bjd.21063. Epub 2022 May 10.

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.原发性皮肤 T 细胞淋巴瘤（蕈样肉芽肿和赛泽里综合征）：第一部分。诊断：临床和组织病理学特征以及新的分子和生物学标志物。

J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2. doi: 10.1016/j.jaad.2013.07.049.

Rapidly progressive tumor stage mycosis fungoides: A case report from Syria.快速进展期蕈样肉芽肿肿瘤分期：来自叙利亚的一例病例报告。

Ann Med Surg (Lond). 2022 Nov 8;84:104834. doi: 10.1016/j.amsu.2022.104834. eCollection 2022 Dec.

Mycosis fungoides development after combined immune checkpoint blockade therapy in a patient with malignant melanoma: a case report.患者在接受恶性黑色素瘤的联合免疫检查点阻断治疗后出现蕈样肉芽肿：病例报告。

Melanoma Res. 2020 Oct;30(5):515-518. doi: 10.1097/CMR.0000000000000664.

Expression of T-cell receptor antigens in mycosis fungoides and inflammatory skin lesions.蕈样肉芽肿及炎症性皮肤病变中T细胞受体抗原的表达

J Invest Dermatol. 1989 Jul;93(1):116-20. doi: 10.1111/1523-1747.ep12277376.

引用本文的文献

Mycosis Fungoides, Sézary Syndrome, and Cutaneous B-Cell Lymphomas: 2025 Update on Diagnosis, Risk-Stratification, and Management.蕈样肉芽肿、塞扎里综合征和皮肤B细胞淋巴瘤：2025年诊断、风险分层及管理的最新进展

Am J Hematol. 2025 Sep;100(9):1603-1628. doi: 10.1002/ajh.27735. Epub 2025 Jun 10.

本文引用的文献

Hyperprogression of cutaneous T cell lymphoma after anti-PD-1 treatment.抗 PD-1 治疗后皮肤 T 细胞淋巴瘤的超进展。

JCI Insight. 2023 Feb 22;8(4):e164793. doi: 10.1172/jci.insight.164793.

Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment.与免疫检查点抑制剂治疗相关的血管免疫母细胞性T细胞淋巴瘤

JAAD Case Rep. 2020 Oct 8;6(12):1264-1267. doi: 10.1016/j.jdcr.2020.09.020. eCollection 2020 Dec.

T-cell lymphoma secondary to checkpoint inhibitor therapy.继发于检查点抑制剂治疗的 T 细胞淋巴瘤。

J Immunother Cancer. 2020 Feb;8(1). doi: 10.1136/jitc-2019-000104.

Pembrolizumab-associated tumor development in a patient with Sézary syndrome.一名蕈样肉芽肿综合征患者中与帕博利珠单抗相关的肿瘤进展

JAAD Case Rep. 2019 Dec 24;6(1):16-18. doi: 10.1016/j.jdcr.2019.11.005. eCollection 2020 Jan.

Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy.抗 PD-1/PD-L1 抑制剂或单药化疗治疗的晚期非小细胞肺癌患者的超进展性疾病。

JAMA Oncol. 2018 Nov 1;4(11):1543-1552. doi: 10.1001/jamaoncol.2018.3676.

Cutaneous CD56 T-cell lymphoma developing during pembrolizumab treatment for metastatic melanoma.在帕博利珠单抗治疗转移性黑色素瘤期间发生的皮肤CD56 T细胞淋巴瘤。

JAAD Case Rep. 2018 Jun 6;4(6):540-542. doi: 10.1016/j.jdcr.2018.01.016. eCollection 2018 Jul.

Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1.抗 PD-1/PD-L1 治疗的癌症患者中出现的一种新的疾病进展模式：超进展性疾病

Clin Cancer Res. 2017 Apr 15;23(8):1920-1928. doi: 10.1158/1078-0432.CCR-16-1741. Epub 2016 Nov 8.

Pembrolizumab versus Ipilimumab in Advanced Melanoma.帕博利珠单抗对比伊匹单抗用于晚期黑色素瘤。

N Engl J Med. 2015 Jun 25;372(26):2521-32. doi: 10.1056/NEJMoa1503093. Epub 2015 Apr 19.

Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?蕈样肉芽肿和塞扎里综合征的预后因素、预后指标和分期：我们现在在哪里？

Br J Dermatol. 2014 Jun;170(6):1226-36. doi: 10.1111/bjd.12909.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验